To understand the biological and clinical relevance of cfDNA methylation in FTD, future studies should also investigate the relationship between DMR scores and markers of neuronal dysfunction (e.g., FDG‐PET and arterial spin labeling MRI) and neurodegeneration (e.g., structural MRI and plasma/CSF neurofilament light chain). This evidence concerns the gene NEFL and frontotemporal dementia.